Walgreens Boots Alliance Inc (WBA) Stake Raised by Piedmont Investment Advisors Inc.
Piedmont Investment Advisors Inc. raised its holdings in Walgreens Boots Alliance Inc (NASDAQ:WBA) by 1.0% during the first quarter, Holdings Channel reports. The institutional investor owned 140,794 shares of the pharmacy operator’s stock after buying an additional 1,372 shares during the quarter. Piedmont Investment Advisors Inc.’s holdings in Walgreens Boots Alliance were worth $8,908,000 at the end of the most recent quarter.
Several other hedge funds have also modified their holdings of WBA. CSat Investment Advisory L.P. raised its stake in shares of Walgreens Boots Alliance by 12.1% in the fourth quarter. CSat Investment Advisory L.P. now owns 1,920 shares of the pharmacy operator’s stock worth $131,000 after purchasing an additional 208 shares during the last quarter. Pathlight Investors LLC bought a new position in shares of Walgreens Boots Alliance in the fourth quarter worth about $524,000. Roman Butler Fullerton & Co. boosted its stake in shares of Walgreens Boots Alliance by 28.8% in the first quarter. Roman Butler Fullerton & Co. now owns 22,127 shares of the pharmacy operator’s stock worth $1,400,000 after acquiring an additional 4,942 shares during the period. James Investment Research Inc. bought a new position in shares of Walgreens Boots Alliance in the fourth quarter worth about $963,000. Finally, Tiemann Investment Advisors LLC boosted its stake in shares of Walgreens Boots Alliance by 2.7% in the fourth quarter. Tiemann Investment Advisors LLC now owns 22,190 shares of the pharmacy operator’s stock worth $1,516,000 after acquiring an additional 586 shares during the period. Hedge funds and other institutional investors own 63.84% of the company’s stock.
In other Walgreens Boots Alliance news, CAO Marco Patrick Anthony Pagni sold 20,000 shares of the company’s stock in a transaction that occurred on Thursday, May 9th. The stock was sold at an average price of $53.05, for a total transaction of $1,061,000.00. Following the sale, the chief accounting officer now directly owns 435,811 shares in the company, valued at $23,119,773.55. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, COO Ornella Barra acquired 18,000 shares of the firm’s stock in a transaction on Wednesday, April 3rd. The shares were bought at an average price of $54.56 per share, for a total transaction of $982,080.00. Following the completion of the transaction, the chief operating officer now owns 26,425 shares of the company’s stock, valued at $1,441,748. The disclosure for this purchase can be found here. Corporate insiders own 15.73% of the company’s stock.
Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings data on Tuesday, April 2nd. The pharmacy operator reported $1.64 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.70 by ($0.06). Walgreens Boots Alliance had a net margin of 3.77% and a return on equity of 22.00%. The company had revenue of $34.53 billion for the quarter, compared to analysts’ expectations of $34.57 billion. During the same quarter last year, the company earned $1.73 earnings per share. The company’s revenue for the quarter was up 4.6% on a year-over-year basis. On average, equities research analysts anticipate that Walgreens Boots Alliance Inc will post 5.99 EPS for the current year.
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, June 12th. Shareholders of record on Monday, May 20th will be given a dividend of $0.44 per share. The ex-dividend date of this dividend is Friday, May 17th. This represents a $1.76 dividend on an annualized basis and a yield of 3.41%. Walgreens Boots Alliance’s dividend payout ratio (DPR) is presently 29.24%.
WBA has been the subject of a number of recent analyst reports. BidaskClub raised Walgreens Boots Alliance from a “sell” rating to a “hold” rating in a research note on Thursday, February 14th. Zacks Investment Research lowered Walgreens Boots Alliance from a “hold” rating to a “sell” rating in a research note on Tuesday, February 26th. Robert W. Baird dropped their price objective on Walgreens Boots Alliance from $70.00 to $67.00 and set a “neutral” rating for the company in a research note on Friday, March 1st. ValuEngine lowered Walgreens Boots Alliance from a “hold” rating to a “sell” rating in a research note on Friday, March 1st. Finally, UBS Group dropped their price objective on Walgreens Boots Alliance from $70.00 to $65.00 and set a “sell” rating for the company in a research note on Monday, March 4th. Five research analysts have rated the stock with a sell rating, twelve have issued a hold rating and four have issued a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and a consensus price target of $67.89.
About Walgreens Boots Alliance
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.
Read More: Buy-Side Analysts
Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.